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Abstract
Coeliac disease (CD) is an inflammatory disorder of the upper small intestine in which gluten acts as an essential factor in
its pathogenesis. Although it is generally accepted that cereal protein activation of the immune system is involved in CD
progression, a non-immunomediated cytotoxic activity of gliadin-derived peptides on the jejunal/duodenal tract cannot be
excluded. In this work, considering that (a) little has been reported about the intracellular metabolic events associated with
gliadin toxicity, and (b) an important role for free radicals in a number of gastrointestinal disease has been demonstrated, we
investigated the in vitro effects of gliadin-derived peptides on redox metabolism of Caco-2 intestinal cells during a kinetic
study in which cells were exposed to peptic^tryptic digest of bread wheat up to 48 h. We found that the antiproliferative
effects displayed by gliadin exposure was associated with intracellular oxidative imbalance, characterised by an increased
presence of lipid peroxides, an augmented oxidised (GSSG)/reduced (GSH) glutathione ratio and a loss in protein-bound
sulfhydryl groups. Significant structural perturbations of the cell plasma membrane were also detected. Additional
experiments performed by using the specific GSH-depleting agent buthionine sulfoximine provide evidence that the extent of
gliadin-induced cell growth arrest critically depends upon the ‘basal’ redox profile of the enterocytes. On the whole, these
findings seem to suggest that, besides the adoption of a strictly gluten-free diet, the possibility for an adjuvant therapy with
antioxidants may be considered for CD patients. ß 1999 Elsevier Science B.V. All rights reserved.
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1. Introduction
Coeliac disease (CD) is a gluten-induced small
bowel enteropathy that occurs in genetically predis-
posed individuals and represents the most chronic
gastrointestinal disease in Europe, with an estimated
prevalence close to 1 in 200 in the general population
[1]. Its typical form is characterised by diarrhoea,
steatorrhoea, weight loss, weakness, nutrition de¢-
ciencies and, histologically, by £at mucosal surface
of small intestine with villous atrophy, crypt cell hy-
perplasia, and in¢ltration of the lamina propria by
lymphocytes, macrophages and plasma cells [2,3].
The causative agent in wheat is the ethanol soluble
prolamin fraction, gliadin, whose toxicity remains
after peptic^tryptic (PT) digestion [4]. The mecha-
nisms by which wheat gliadins and prolamins from
other cereals known to be toxic for coeliac patients
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(rye, oats and barley) produce the above-mentioned
lesions in the small intestine of CD subjects are not
fully understood. While most investigators favour a
dysregulated immune response to gliadins as the
underlying abnormality in CD [2], several in vitro
studies have demonstrated a non-immunomediated
cytotoxic activity of gliadin-derived peptides against
enterocytes, inversely correlated with the di¡erentia-
tion of the cell phenotype. In particular, prolamins
toxic for coeliacs are able to inhibit the development
and morphogenesis of the small intestine from 17-
day-old rat foetuses but have no e¡ect on the culture
of di¡erentiated jejunum from 21-day-old rat foe-
tuses or newborn rats [5,6]. Moreover, gliadin pep-
tides are toxic to the in vitro cultured atrophic coe-
liac mucosa, lined with immature enterocytes,
whereas are non-toxic to histologically normal coe-
liac small intestinal mucosa in remission [7]. In addi-
tion, they are capable of activating mucosal lympho-
cytes and macrophages without epithelial cell
proliferation in small intestine biopsies of patients
with CD [8], and to agglutinate undi¡erentiated hu-
man K562 cells [9,10]. Finally, our previous studies
have demonstrated that prolamins toxic for coeliacs
are able to in vitro exert a direct antiproliferative and
antimetabolic e¡ect against the Caco-2 intestinal cell
line [10^13], a suitable model for the study of many
parameters of enterocyte function [14]. By contrast,
prolamins derived from cereals considered as non-
toxic (maize, durum wheat) were inactive in inhibit-
ing the Caco-2 cell proliferation [11].
During the past years, evidences have accumulated
which demonstrate that the balance of the oxidative
and reductive potential within the cell can have pro-
found consequences on several cellular functions [15].
In fact, a role for free radicals in a variety of human
disorders including gastrointestinal disease has been
demonstrated [16,17]. In this work, in order to clarify
the role of intracellular redox environment on the
cereal-induced cytopathology, we investigated the in
vitro e¡ect of gliadin-derived peptides on redox me-
tabolism of undi¡erentiated Caco-2 cells during a
kinetic study in which the cells were exposed to PT
digest of bread wheat. In particular, the fate of both
soluble (glutathione) and protein thiols and the ef-
fects on plasma membrane have been followed at
di¡erent times of exposure of the cells to PT digest
of wheat gluten. The results obtained, which show
that the gliadin-induced cell growth arrest is associ-
ated with an emerging internal pro-oxidant condi-
tion, seem to be suggestive of a close relationship
between the redox state of enterocytes and their sus-
ceptibility to gliadins.
2. Materials and methods
2.1. Preparation of cereal digest
Pure hexaploid bread wheat (Triticum aestivum,
variety S. Pastore) was kindly supplied by the Istitu-
to Sperimentale per la Cerealicoltura, Rome. Gliadin
was extracted as described previously by Auricchio et
al. [5]. The protein fraction was submitted to peptic^
tryptic (PT) sequential digestion according to De Ri-
tis et al. [18], to obtain the corresponding PT digest.
At the end of the whole procedure, PT digest was
heated for 30 min at 100‡C, lyophilised, and stored
at 320‡C until use.
2.2. Cell culture and treatments
The human colon carcinoma cell line Caco-2 was
grown in Dulbecco’s modi¢ed Eagle’s medium
(DMEM, HyClone Europe) supplemented with 0.2
mM L-glutamine, 1% non-essential amino acids (Hy-
Clone), 5 U/ml penicillin, 5 Wg streptomycin and 10%
(v/v) foetal bovine serum (Northumbria Biological,
Cramlington, UK), and maintained at 37‡C in a
5% CO2/95% air atmosphere. For experiments, cells
were seeded at a density of 9U104/ml in 25-cm2 tis-
sue culture £asks (Falcon) and were allowed to at-
tach to the substrate in 5 ml of the medium for 48 h.
Then, the culture medium was replaced by 5 ml of
DMEM with or without 1 mg/ml PT digest of pure
hexaploid bread wheat, and the cells were incubated
for 6, 24 and 48 h. The PT digest concentration used
in the present investigation was chosen on the basis
of experiments previously published by our group
[11^13]. In selected experiments, cells were pre-
treated for 24 h with 50 WM of the speci¢c GSH-
depleting agent buthionine sulfoximine (BSO, Sigma,
St. Louis, MO, USA). At each endpoint, cells were
harvested, centrifuged for 5 min at 900 rpm, washed
twice with phosphate-bu¡ered saline (PBS) solution
(pH 7.4), resuspended in the same bu¡er and homo-
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genised by sonication for 30 s in a Soniprep 150.
Aliquots of the cell lysates were diluted with 1 vol
of 10% (w/v) of ice-cold 5-sulfosalicylic acid (Sigma)
and utilised for glutathione and protein sulfydryl
groups measurements, while resting aliquots were
used for determination of both cell lipid peroxides
and protein content. Cell proliferation after all the
treatments was followed by counting the total num-
ber of cells in each £ask. For this purpose, at the end
of each experiment, cells previously trypsinised were
washed with PBS and resuspended with 10 volumes
of isotonic saline solution before the cells were
counted in a Coulter counter. To evaluate the num-
ber of detached cells after treatments, the medium
previously collected was centrifuged at 900 rpm for
5 min. Cell pellets were washed twice with PBS, re-
suspended in 1 ml of the same bu¡er and counted in
a cell-counting chamber. Cell viability was evaluated
by Trypan blue dye exclusion test.
2.3. Determination of cell lipid peroxidation
4-Hydroxy-2(E)-nonenal (4-HNE) is an important
decomposition product of peroxides derived from
polyunsaturated fatty acids (PUFA) and related es-
ters, which speci¢cally detect the peroxidative break-
down of g6-PUFA. Thus, measurement of 4-HNE
provide a convenient index of lipid peroxidation
[19,20]. Assay for cellular 4-HNE content was carried
out using the commercially available LPO-586 kit
from Bioxytech (Bonneuil Sur Marne, France), fol-
lowing the manufacturer’s instructions. Data, ex-
pressed as nmol of 4-HNE per mg of protein, were
evaluated on the basis of a 4-HNE calibration curve.
2.4. Determination of oxidised (GSSG) and reduced
(GSH) glutathione
To determine the total intracellular glutathione
content, the enzymatic recycling assay with gluta-
thione reductase (type IV, Sigma) and 5,5P-dithio-
bis-2-nitrobenzoic acid (DTNB, Sigma) was used,
essentially according to Anderson [21]. The acidi¢ed
homogenates obtained with 5-sulfosalicylic acid as
described above were centrifuged in a microfuge
(6000 rpm) at 4‡C for 10 min to remove the protein
precipitate, and the clear supernatants were stored at
4‡C until assayed. Total glutathione was estimated
by monitoring the formation of the chromophoric
product 2-nitro-5-thiobenzoic acid (TNB) at 412
nm in the presence of glutathione reductase and
NADPH. For the measurement of GSSG, the acidi-
¢ed homogenates were submitted to derivatisation
with undiluted 2-vinylpyridine (Aldrich, Milwaukee,
WI, USA) in presence of triethanolamine (Sigma) for
1 h at room temperature. Samples were then assayed
by means of the same procedure described above for
total glutathione measurement. The amount of both
total glutathione and GSSG in the sample were de-
termined from a standard curve obtained by plotting
know amount of GSH and GSSG (both from Sig-
ma), incubated in the respective experimental condi-
tions, vs. the rate of change of absorbance at 412 nm.
The amount of GSH present in the samples was cal-
culated as the di¡erence between total glutathione
and GSSG levels. Data were expressed as nmol of
GSH or GSSG per mg protein.
2.5. Determination of protein sulfydryl groups
Protein sulfydryl groups were measured as de-
scribed by Di Monte et al. [22]. Cell pellets previ-
ously precipitated with ice-cold 5-sulfosalicylic acid
were washed twice with 5% (w/v) of the same solu-
tion and were ¢nally resuspended in 0.5 M Tris^HCl,
pH 7.6. DTNB (100 WM ¢nal concentration) was
then added and, after 20 min, the absorbance was
measured at 420 nm. Data were expressed as nmol
of SH per mg protein, calculated on the basis of a
GSH calibration curve.
2.6. Plasma membrane study
In order to evaluate the e¡ects of gliadin^mem-
brane interaction on the structure of the Caco-2
cell membrane, we used the speci¢c probe Annexin
V, a member of a calcium- and phospholipid-binding
family of proteins capable of selectively binding to
cells with a compromised membrane asymmetry [23].
For this purpose, both control and PT-treated cells
were grown on glass coverslips in separate wells, and
then processed for immuno£uorescence analysis as
previously described [24]. Brie£y, cells were washed
three times in a speci¢c ice-cold bu¡er (10 mM
Hepes, 150 mM NaCl, 5 mM KCl, 1 mM MgCl2,
1.8 mM CaCl2, pH 7.4), and then incubated with
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FITC-conjugated Annexin V (Bender MedSystem,
¢nal dilution 1 mg/ml in the above bu¡er) at 4‡C
for 40 min. Finally, cells were ¢xed with ice-cold
3% paraformaldehyde in PBS for 20 min at 4‡C,
mounted with glycerol/PBS (2:1), and observed
with a Nikon Microphot £uorescence microscope.
2.7. Protein content
The protein concentration was measured by the
commercially available Coomassie brilliant blue
dye-binding assay (Bio-Rad, Hercules, CA, USA),
following the manufacturer’s instructions. Bovine se-
rum albumin was used as a standard.
2.8. Statistical analysis
Each experiment was repeated at least four times
and data were presented as the mean þ standard de-
viation. Statistical signi¢cance among the groups was
determined using the unpaired two-tailed Student’s
t-test. A P-value of less than 0.05 was taken to re£ect
a signi¢cant di¡erence.
3. Results
3.1. PT-Digest of bread wheat a¡ects cell
proliferation
As can be observed in Fig. 1, cell growth in a
medium containing 1 mg/ml of PT gliadin digest
was impaired when compared to cells grown under
normal conditions, particularly after 24 h and 48 h of
PT exposure, in which an inhibition of about 20%
(P6 0.05) was found. In order to ascertain whether
the inhibition of cell proliferation was GSH-depend-
ent, experiments in which 50 WM of the speci¢c GSH
depletor BSO (a selective inhibitor of Q-glutamylcys-
teine synthetase, the rate-limiting enzyme in GSH
production) was added in the medium 24 h before
the PT treatment was carried out. As can be ob-
served, the combined treatment BSOCPT showed
a partial cumulative e¡ect, with a slight but signi¢-
cant (P6 0.05, evaluated at 24 h and 48 h) e¡ect on
the cell growth arrest, estimable in a further inhib-
ition of 10% vs. PT-treated cells. By contrast, cells
treated with BSO alone displayed the same prolifer-
ative index of controls.
An estimation of the number of the cells £oating
in the medium as consequence of detachment from
the substrate, performed as described in Section 2,
showed that the number of detached cells founded
after gliadin exposure was substantially the same of
controls. Finally, viability of the cells evaluated by
Trypan blue exclusion test did not show any signi¢-
cant di¡erences between PT-treated and untreated
cells. These results con¢rm those previously reported
by our group using di¡erent toxic and non-toxic ce-
reals [11^13], which have demonstrated the e¡ect es-
sentially antiproliferative and antimetabolic of toxic
cereals on Caco-2 cells.
3.2. PT-Induced cell growth arrest is associated with
an emerging pro-oxidant condition
To determine whether the antiproliferative e¡ect of
gliadin on intestinal cells was associated with internal
oxidative modi¢cation, we ¢rstly investigated the ex-
tent of cellular lipid peroxidation. Incubation of
Caco-2 cells for 48 h with 1 mg/ml of PT digest of
bread wheat resulted in a signi¢cant (P6 0.05) incre-
ment of 33%, 50%, and 37% in lipid peroxides asso-
Fig. 1. E¡ect of in vitro PT-digest of bread wheat treatment on
the growth of Caco-2 cells. At each endpoint of treatment se-
lected, cells were harvested and cell number per £ask was
counted in a Coulter counter. As can be observed, gliadin is ca-
pable to exert a signi¢cant antiproliferative e¡ect that appears
to partially depend, in consideration of the experiments per-
formed with the BSO pre-treatment (BSOCPT), by the initial
GSSG/GSH ratio of the cells. The means and standard devia-
tions of six separate experiments are represented. *P6 0.05 vs.
untreated cells ; ‡P6 0.05 vs. PT-treated cells.
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ciated with the cells, estimated as 4-HNE at 6, 24
and 48 h, respectively, of PT exposure (Fig. 2).
In view of these e¡ects and considering the role of
GSH as one of the most important intracellular de-
fence against oxidative damage, a speci¢c analysis on
intracellular GSH and GSSG levels in Caco-2 cells
exposed to 1 mg/ml of PT digest of bread wheat for
times up to 48 h was carried out. The results of this
time course are shown respectively in Fig. 3a,b. As
can be observed, 6 h after PT addition, a 12% drop
in GSH concentration (P6 0.05) and a 2.7-fold in-
crease of GSSG level (P6 0.01) were found. After
24 h of treatment, the drop of GSH content reached
the maximum level, with a loss of 20% (P6 0.01)
with respect to untreated cells. By contrast, a parallel
4.4-fold increase of GSSG (P6 0.001) was found.
Finally, at 48 h a decrease of 18% in GSH levels
(P6 0.05) with a parallel 1.9-fold increase in GSSG
content (P6 0.05) were found. Experiments per-
formed in order to depress basal GSH values of
the cells by a speci¢c treatment with 50 WM BSO
for 24 h showed that this concentration was able to
reduce the intracellular GSH levels to about 80%
with respect to control values (Fig. 3a) without, as
mentioned above, any signi¢cant e¡ects on the char-
acteristic of the cell growth (Fig. 1). However, when
24-h BSO-treated cells were incubated in presence of
1 mg/ml of wheat gliadin (BSOCPT), the further
inhibition of the cell growth observed with respect
to cells treated with PT alone (Fig. 1) was not ac-
companied by a simultaneous decrease in the already
depressed GSH concentration in the cells (Fig. 3a).
The e¡ects of PT exposure on GSH homeostasis
prompted us to investigate the in£uence of treatment
on protein-bound sulfydryl groups. As shown in Fig.
4, there was a progressive disappearance in protein
thiols (SH) after addition of 1 mg/ml of gliadin to the
incubation medium, particularly evident after 24 h of
treatment (320%, P6 0.01). Finally, a drop of 17%
(P6 0.05) in SH-protein groups was detected after
48 h of PT-exposure, with respect to untreated cells.
Fig. 3. E¡ect of PT treatment on intracellular GSH and GSSG
levels. Forty-eight hours after seeding, cells were incubated with
1 mg/ml of PT-digest of bread wheat, and the incubation con-
tinued for 48 h. The cells were then harvested, and both GSH
(a) and GSSG (b) levels were measured as described in Section
2. The e¡ect of 24 h of 50 Wm BSO pre-treatment is also pro-
vided (a). The means and standard deviations of four separate
experiments are shown. *P6 0.05, **P6 0.01, ***P6 0.001 vs.
untreated cells.
Fig. 2. Cellular lipid peroxidation, evaluated by the formation
of 4-HNE, induced by PT treatment of Caco-2 cells up to 48 h.
The means and standard deviations of four separate experi-
ments are shown. *P6 0.05 vs. untreated cells.
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3.3. PT treatment induces plasma membrane
perturbation
Because of the results obtained above, particularly
those involving lipid peroxidation processes, and in
order to better clarify the e¡ects of gliadin^mem-
brane interaction on the membrane structure during
PT exposure, an immuno£uorescence analysis using
the probe Annexin V-FITC (a protein that is predis-
posed to bind phosphatidylserine that, normally, is a
component of the inner membrane over most other
phospholipid species [23]) was carried out. As can be
observed, gliadin-treated cells showed an evident
positive reaction for phosphatidylserine at each end-
point selected, as result of the exposure of the cell’s
inner phospholipid to the exterior (Fig. 5b^d, in
which 6, 24, and 48 h of treatments, respectively,
are displayed). By contrast, labelling of untreated
cells (Fig. 5a, 48-h cultured cells are provided) ap-
Fig. 5. Evaluation of gliadin^membrane interaction in Caco-2 cells by £uorescence microscopy using as speci¢c probe vs. phosphati-
dylserine Annexin V-FITC. (a) 48-h untreated cells and cells treated with 1 mg/ml of PT-digest of pure hexaploid bread wheat for (b)
6 h, (c) 24 h, and (d) 48 h. As can be observed, PT-treated cells show a positive reaction for phosphatidylserine, due to the exposure
of the cell’s inner phospholipids to the exterior. Magni¢cation: U2800.
Fig. 4. Evaluation of protein thiols (SH) in control and 1 mg/
ml PT-treated Caco-2 cells at 6, 24, and 48 h of treatment. As
can be seen, a signi¢cant disappearance of SH-groups occurs
after 24 h of treatment, remaining stable at 48 h. The means
and standard deviations of four separate experiments are
shown. *P6 0.05, **P6 0.01 vs. untreated cells.
BBADIS 61797 28-12-98
R. Rivabene et al. / Biochimica et Biophysica Acta 1453 (1999) 152^160 157
peared to be always negative, demonstrating a sub-
stantially well preserved membrane integrity.
4. Discussion
The mechanism(s) by which wheat gliadins and
prolamins from other ‘toxic’ cereals produce damage
to the coeliac small intestine is still unknown. Ac-
tually, there is overwhelming evidence that mucosal
lesions in gluten sensitivity are initiated within the
lamina propria and are due to MHC class-2 express-
ing activated macrophages that present antigen to
CD4 lymphocytes. These, in turn, produce high lev-
els of pro-in£ammatory cytokines that are responsi-
ble for many of the phlogistic changes within the
lamina and the epithelium [2,3]. However, beside
this immunologic pathway, the direct cytotoxic ac-
tion of gliadin peptides against immature enterocytes
has been postulated as one of the mechanisms under-
lying the pathogenesis and the progression of CD
[11^13,25,26].
In this work, we show that the in vitro antiproli-
ferative activity exerted by gliadin-derived peptides
on undi¡erentiated Caco-2 intestinal cells is associ-
ated with a modi¢cation of intracellular redox bal-
ance characterised by an altered GSSG/GSH ratio
and a signi¢cant reduction in SH-protein groups.
This seems to be the result of the gliadin^enterocyte
interaction, mainly occurring via lectin receptors
which are present in large quantity on the Caco-2
cell membrane [27,28] (but other ways of binding/
uptake of gliadin peptides cannot be excluded [29]).
The event is capable of triggering a number of mod-
i¢cations in the structure and function of the mem-
brane that, in turn, can a¡ect the signal transduction
pathway involved in the cell cycle control. To explain
such in vitro e¡ects, two di¡erent aspects should be
considered: the release of lipid peroxides inside the
cells, and the translocation of phosphatidylserine
from the inner lea£et to the extracellular side of
the plasma membrane. Regarding the ¢rst aspect, a
positive correlation between the increased levels of
products of lipid peroxidation, such as 4-HNE, and
the ‘down-regulation’ of cell proliferation has been
demonstrated [15,30]. Moreover, the observed pro-
duction of alkenals during PT treatment can modify
the activity of membrane-associated proteins and en-
zymes [19]. Finally, damage to PUFA can lead to
changes in both membrane £uidity (rigidisation)
and permeability characteristics [31], conditions
which are capable of altering protein and enzyme
function [32]. Considering the second point, it is
well known that certain membrane receptors, trans-
porters and enzymes are sensitive to the structural
and physical properties of the lipids with which
they interact. The changes in these two parameters
may a¡ect the lateral mobility of these proteins with-
in the lipid bilayer and their interactions with other
membrane components. On the whole, all these
membrane perturbations may produce functional
changes in those membrane-associated proteins that
play important roles in proliferative signal transduc-
tion [32], leading to a re-modulation of the network
of signals inside the cell.
Although the altered GSSG/GSH equilibrium ob-
served after PT treatment could be considered as a
downstream event of alkenals release into the cell,
the experiments in which the internal GSH level
was previously depressed using the BSO pre-treat-
ment seem to suggest that the ‘basal’ redox environ-
ment of the enterocyte (its pre-existing GSSG/GSH
ratio) can modulate, at least partially, its in vitro
susceptibility to gliadin. This observation appears
to be reinforced by the results obtained on protein
sulfydryl groups, the major loss of which during PT
treatment occurs only subsequent to the depletion of
cellular GSH. This may suggest, as reported by
others [22], that this soluble thiol represents a pro-
tective agent against the disappearance of the former
and also for oxidative modi¢cation of proteins.
Several investigations have demonstrated the in-
volvement of free radicals in the progression of a
number of gastrointestinal diseases, particularly idio-
pathic in£ammatory bowel diseases [17,33,34]. This
situation, almost certainly participating to the devel-
opment of the ‘£orid’ phase of CD (in which the
subtotal or partial villous atrophy at jejunal or duo-
denal level as a consequence of a di¡use in£ammatory
process occurs [35]), may constitute the premise for a
systemic redox imbalance. In fact, it has been demon-
strated that CD patients have erythrocytes with a
reduced protective capacity against in vitro induced
oxidative stress [36] and present an increase propen-
sity in both their circulating low density lipoproteins
and chylomicrons to lipid peroxidation [37].
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In conclusion, our results indicate that the gliadin^
enterocyte interaction process is able per se to a¡ect
the intracellular redox metabolism, inducing a sort of
‘mild’ oxidative stress. If the in vitro e¡ects of gliadin
appear to be antiproliferative rather than lethal to
cells, the simultaneous in vivo presence of an altered
cytokine network due to the above-mentioned in-
£ammatory process and characterised essentially by
a switch to the Th1 pro¢le [38], may represent an
important additive aspect in determining the toxic
e¡ects of gluten in CD subjects.
Further studies are needed to evaluate the possi-
bility to prevent/counteract the in vitro gliadin-in-
duced cytopathology, by treating the cells with di¡er-
ent antioxidants. However, the present ¢ndings seem
to suggest that the redox state of the enterocytes may
represent a critical point for the development of in-
testinal lesions in CD. This raises the possibility, ad-
vanced by other authors [37], that besides the current
clinical approach proposed for coeliac patients based
essentially on the adoption of a strictly gluten-free
diet, both a supplementation of the diet with antiox-
idant nutrients and/or administration of drugs hav-
ing antioxidant properties could be bene¢cial for CD
therapy.
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